Proprietary AI analyst is now available

Luyan Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Luyan Pharma and similar public comparables like Genky Drug Stores, Zjamp Group, Farmacias Benavides, Cachet Pharmaceuticals and more.

Luyan Pharma Overview

About Luyan Pharma

Luyan Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.


Founded

2008

HQ

China

Employees

5.6K

Sectors

Financials (FY)

Revenue: $3B
EBITDA: $103M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Luyan Pharma Financials

Luyan Pharma reported last fiscal year revenue of $3B and EBITDA of $103M.

In the same fiscal year, Luyan Pharma generated $223M in gross profit, $103M in EBITDA, and $42M in net income.


Luyan Pharma P&L

In the most recent fiscal year, Luyan Pharma reported revenue of $3B and EBITDA of $103M.

Luyan Pharma is profitable as of last fiscal year, with gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.

See analyst estimates for Luyan Pharma
Last FY202320242025202620272028
Revenue$3B$3B$3B$3B
Gross Profit$223M$223M$226M$223M
Gross Margin7%8%7%7%
EBITDA$103M$121M$117M$103M
EBITDA Margin3%4%4%3%
EBIT Margin3%4%3%3%
Net Profit$42M$54M$51M$42M
Net Margin1%2%2%1%
Net Debt$562M---

Financial data powered by Morningstar, Inc.

Luyan Pharma Stock Performance

Luyan Pharma has current market cap of $645M, and enterprise value of $1B.

Market Cap Evolution


Luyan Pharma's stock price is $1.66.

Luyan Pharma share price decreased by 5.0% in the last 30 days, and increased by 33.4% in the last year.

Luyan Pharma has an EPS (earnings per share) of $0.11.

See more trading valuation data for Luyan Pharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$645M-0.6%-5.0%-30.0%33.4%$0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Luyan Pharma Valuation Multiples

Luyan Pharma trades at 0.4x EV/Revenue multiple, and 13.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Luyan Pharma

Luyan Pharma Financial Valuation Multiples

As of June 17, 2026, Luyan Pharma has market cap of $645M and EV of $1B.

Luyan Pharma has a P/E ratio of 15.5x.

Last FY202320242025202620272028
EV/Revenue0.4x0.5x0.4x0.4x
EV/EBITDA13.0x11.0x11.4x13.0x
EV/EBIT15.1x12.5x13.1x15.1x
EV/Gross Profit6.0x6.0x5.9x6.0x
P/E15.5x12.0x12.6x15.5x
EV/FCF19.9x11.6x41.8x19.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Luyan Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Luyan Pharma Margins & Growth Rates

In the most recent fiscal year, Luyan Pharma reported gross margin of 7%, EBITDA margin of 3%, and net margin of 1%.

See estimated margins and future growth rates for Luyan Pharma

Luyan Pharma Margins

Last FY20242025202720282029
Gross Margin7%7%7%
EBITDA Margin3%4%3%
EBIT Margin3%3%3%
Net Margin1%2%1%
FCF Margin2%1%2%

Luyan Pharma Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth3%4%
Gross Profit Growth1%(1%)
EBITDA Growth(3%)(13%)
EBIT Growth(4%)(14%)
Net Profit Growth(5%)(19%)
FCF Growth(72%)110%

Data powered by FactSet, Inc. and Morningstar, Inc.

Luyan Pharma Operational KPIs

Luyan Pharma's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Luyan Pharma
Last FY202320242025202620272028
Revenue per Employee$0.6M---
Opex per Employee$0.0M---
S&M Expenses to Revenue0%0%0%0%
G&A Expenses to Revenue0%0%0%0%
R&D Expenses to Revenue0%0%0%0%
Opex to Revenue4%4%4%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Luyan Pharma Competitors

Luyan Pharma competitors include Genky Drug Stores, Zjamp Group, Farmacias Benavides, Cachet Pharmaceuticals, Pague Menos, DocMorris, Cawachi, Shu Yu Civilian Pharmacy, Apotea and JZJ Chain Drugstore.

Most Luyan Pharma public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Genky Drug Stores0.6x0.6x7.4x7.3x
Zjamp Group0.0x-0.5x-
Farmacias Benavides0.8x-7.3x-
Cachet Pharmaceuticals0.2x-7.9x-
Pague Menos0.4x0.4x5.1x5.9x
DocMorris0.5x0.4x(12.5x)(12.9x)
Cawachi0.2x0.2x5.6x-
Shu Yu Civilian Pharmacy0.7x-10.4x-

This data is available for Pro users. Sign up to see all Luyan Pharma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Luyan Pharma

When was Luyan Pharma founded?Luyan Pharma was founded in 2008.
Where is Luyan Pharma headquartered?Luyan Pharma is headquartered in China.
How many employees does Luyan Pharma have?As of today, Luyan Pharma has over 5K employees.
Is Luyan Pharma publicly listed?Yes, Luyan Pharma is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Luyan Pharma?Luyan Pharma trades under 002788 ticker.
When did Luyan Pharma go public?Luyan Pharma went public in 2016.
Who are competitors of Luyan Pharma?Luyan Pharma main competitors include Genky Drug Stores, Zjamp Group, Farmacias Benavides, Cachet Pharmaceuticals, Pague Menos, DocMorris, Cawachi, Shu Yu Civilian Pharmacy, Apotea, JZJ Chain Drugstore.
What is the current market cap of Luyan Pharma?Luyan Pharma's current market cap is $645M.
What is the current revenue of Luyan Pharma?Luyan Pharma's last fiscal year revenue is $3B.
What is the current EV/Revenue multiple of Luyan Pharma?Current revenue multiple of Luyan Pharma is 0.4x.
Is Luyan Pharma profitable?No, Luyan Pharma is not profitable.
How many companies Luyan Pharma has acquired to date?Luyan Pharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Luyan Pharma has invested to date?Luyan Pharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Luyan Pharma

Lists including Luyan Pharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial